Related Experiment Videos
[Nitric oxide: the endogenous nitrate in the cardiovascular system]
1Department Medizin, Inselspital Bern/Schweiz.
Herz
|June 1, 1996
Summary
The endothelium produces nitric oxide (NO) from L-arginine, regulating vascular tone and preventing blood clots. This endogenous nitrovasodilator is crucial for maintaining blood flow, with therapeutic nitrates offering a substitute when NO production is impaired.
Area of Science:
- Biochemistry
- Physiology
- Pharmacology
Context:
- The endothelium regulates vascular tone via relaxing and contracting factors.
- The L-arginine pathway in endothelial cells produces nitric oxide (NO).
- NO measurement is analytically challenging due to its reactivity.
Purpose:
- To elucidate the role of the endothelial L-arginine pathway in vascular homeostasis.
- To describe the mechanisms of nitric oxide (NO) production and action.
- To highlight the therapeutic potential of nitrates in conditions of impaired NO synthesis.
Summary:
- Nitric oxide (NO), synthesized from L-arginine via NO synthase, mediates endothelium-dependent relaxation by activating soluble guanylyl cyclase, leading to vasodilation.
- NO also exhibits anti-aggregatory effects on platelets and inhibits vasoconstrictor peptide endothelin-1 production.
- Therapeutic nitrates release NO, mimicking endogenous effects, particularly beneficial in arteries with impaired NO synthesis or absent endothelium.
Impact:
- Endothelium-derived NO is vital for preventing vasospasm and thrombus formation, ensuring adequate blood flow to organs.
- NO's vasodilator and antiplatelet properties are critical for maintaining cardiovascular health.
- Nitrates can compensate for impaired endogenous NO production, offering therapeutic benefits in cardiovascular diseases.